Dr. Minkowitz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 Citywest Blvd
Ste 300
Houston, TX 77042Phone+1 972-233-1999- Is this information wrong?
Education & Training
- University of the WitwatersrandClass of 1988
Certifications & Licensure
- TX State Medical License 1997 - 2026
- IA State Medical License 1995 - 2000
- American Board of Anesthesiology Anesthesiology
Clinical Trials
- Pharmacokinetic Evaluation of EXPAREL in Adults Undergoing Tonsillectomy Start of enrollment: 2014 Aug 01
- Study of APD421 as PONV Treatment (no Prior Prophylaxis) Start of enrollment: 2015 Sep 01
Publications & Presentations
PubMed
- 36 citationsATHENA: A Phase 3, Open-Label Study Of The Safety And Effectiveness Of Oliceridine (TRV130), A G-Protein Selective Agonist At The µ-Opioid Receptor, In Patients With M...Sergio D. Bergese, Marek Brzezinski, Gregory B. Hammer, Timothy L Beard, Peter H. Pan
Journal of Pain Research. 2019-11-14 - 111 citationsA randomized, Phase IIb study investigating oliceridine (TRV130), a novel µ-receptor G-protein pathway selective (μ-GPS) modulator, for the management of moderate to s...Neil Singla, Harold S. Minkowitz, David G. Soergel, David A. Burt, Ruth Ann Subach
Journal of Pain Research. 2017-10-06 - 70 citationsSafety and Side Effect Profile of Liposome Bupivacaine (Exparel) in Peripheral Nerve Blocks.Brian M. Ilfeld, Eugene R. Viscusi, Admir Hadzic, Harold S. Minkowitz, Michael Morren
Regional Anesthesia and Pain Medicine. 2015-09-01
Press Mentions
- Concentric Analgesics Forges Important Phase 3 Clinical Relationships for Vocacapsaicin, a Non-Opioid Pain Therapy Targeting TRPV1 ReceptorFebruary 2nd, 2022
- Sorrento Therapeutics and Mount Sinai Join Forces to Develop Covid-19 Antibody ShieldMay 8th, 2020
- Should FDA Approve ‘Super Opioid’ That’s Stronger Than Fentanyl?October 25th, 2018
- Join now to see all
Hospital Affiliations
- Memorial Hermann Katy HospitalKaty, Texas
- Memorial Hermann Memorial City Medical CenterHouston, Texas
- Memorial Hermann Physician NetworkHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: